Endoscopy 2016; 48(04): 373-379
DOI: 10.1055/s-0034-1393560
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Use of patency capsule in patients with established Crohn’s disease

Artur Nemeth*
1   Department of Gastroenterology, Skåne University Hospital, Lund University, Malmö, Sweden
,
Uri Kopylov*
2   Division of Gastroenterology, McGill University Health Center, Montreal, Quebec, Canada
3   Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Israel
,
Anastasios Koulaouzidis
4   Endoscopy Unit, Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Scotland, United Kingdom
,
Gabriele Wurm Johansson
1   Department of Gastroenterology, Skåne University Hospital, Lund University, Malmö, Sweden
,
Henrik Thorlacius
5   Department of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden
,
Devendra Amre
6   Research Institute, Saint Justine Medical Center, Universite de Montreal, Montreal, Quebec, Canada
,
Rami Eliakim
3   Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Israel
,
Ernest G. Seidman
2   Division of Gastroenterology, McGill University Health Center, Montreal, Quebec, Canada
,
Ervin Toth
1   Department of Gastroenterology, Skåne University Hospital, Lund University, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

submitted: 25 February 2015

accepted after revision: 20 September 2015

Publication Date:
12 November 2015 (online)

Background and study aims: Video capsule endoscopy (VCE) is invaluable in the diagnosis of small-bowel pathology. Capsule retention is a major concern in patients with Crohn’s disease. The patency capsule was designed to evaluate small-bowel patency before VCE. However, the actual benefit of the patency capsule test in Crohn’s disease remains unclear. The aim of this study was to evaluate the clinical impact of patency capsule use on the risk of video capsule retention in patients with established Crohn’s disease.

Patients and methods: This was a retrospective, multicenter study of patients with established Crohn’s disease who underwent VCE for clinical need. The utilization strategy for the patency capsule was classified as selective (only in patients with obstructive symptoms, history of intestinal obstruction or surgery, or per treating physician’s request) or nonselective (all patients with Crohn’s disease). The main outcome was video capsule retention in the entire cohort and within each utilization strategy.

Results: A total of 406 patients who were referred for VCE were included in the study. VCE was performed in 132 /406 patients (32.5 %) without a prior patency capsule test. The patency capsule test was performed in 274 /406 patients (67.5 %) and was negative in 193 patients. Overall, VCE was performed in 343 patients and was retained in the small bowel in 8 (2.3 %). In this cohort, the risk of video capsule retention in the small bowel was 1.5 % without use of a prior patency capsule and 2.1 % after a negative patency test (P = 0.9). A total of 18 patients underwent VCE after a positive patency capsule test, with a retention rate of 11.1 % (P = 0.01). Patency capsule administration strategy (selective vs. nonselective) was not associated with the risk of video capsule retention.

Conclusions: Capsule retention is a rare event in patients with established Crohn’s disease undergoing VCE. The risk of video capsule retention was not reduced by the nonselective use of the patency capsule. Furthermore, VCE after a positive patency capsule test in patients with Crohn’s disease was associated with a high risk of video capsule retention.

* These authors contributed equally to this work.


 
  • References

  • 1 Kopylov U, Seidman EG. Clinical applications of small bowel capsule endoscopy. Clin Exp Gastroenterol 2013; 6: 129-137
  • 2 Cosnes J, Gower-Rousseau C, Seksik P et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794
  • 3 Wang A, Banerjee S, Barth BA et al. Wireless capsule endoscopy. Gastrointest Endosc 2013; 78: 805-815
  • 4 Kopylov U, Seidman EG. Role of capsule endoscopy in inflammatory bowel disease. World J Gastroenterol 2014; 20: 1155-1164
  • 5 Hall BJ, Holleran GE, Smith SM et al. A prospective 12-week mucosal healing assessment of small bowel Crohn’s disease as detected by capsule endoscopy. Eur J Gastroenterol Hepatol 2014; 26: 1253-1259
  • 6 Hall B, Holleran G, Costigan D et al. Capsule endoscopy: high negative predictive value in the long term despite a low diagnostic yield in patients with suspected Crohn’s disease. United European Gastroenterol J 2013; 1: 461-466
  • 7 Hall B, Holleran G, Chin JL et al. A prospective 52 week mucosal healing assessment of small bowel Crohn’s disease as detected by capsule endoscopy. J Crohns Colitis 2014; 8: 1601-1609
  • 8 Mow WS, Lo SK, Targan SR et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 31-40
  • 9 Cheifetz AS, Kornbluth AA, Legnani P et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn’s disease. Am J Gastroenterol 2006; 101: 2218-2222
  • 10 Cave D, Legnani P, de Franchis R et al. ICCE consensus for capsule retention. Endoscopy 2005; 37: 1065-1067
  • 11 Postgate AJ, Burling D, Gupta A et al. Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review. Dig Dis Sci 2008; 53: 2732-2738
  • 12 Annese V, Daperno M, Rutter MD et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018
  • 13 Gralnek IM, Defranchis R, Seidman E et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008; 27: 146-154
  • 14 Cotter J, Dias de Castro F, Magalhaes J et al. Validation of the Lewis score for the evaluation of small-bowel Crohn’s disease activity. Endoscopy 2015; 47: 330-335
  • 15 Cotter J, Dias de Castro F, Moreira MJ et al. Tailoring Crohn’s disease treatment: the impact of small bowel capsule endoscopy. J Crohns Colitis 2014; 8: 1610-1615
  • 16 Dussault C, Gower-Rousseau C, Salleron J et al. Small bowel capsule endoscopy for management of Crohn’s disease: a retrospective tertiary care centre experience. Dig Liver Dis 2013; 45: 558-561
  • 17 Leighton JA, Gralnek IM, Cohen SA et al. Capsule endoscopy is superior to small-bowel follow-through and equivalent to ileocolonoscopy in suspected Crohn’s disease. Clin Gastroenterol Hepatol 2014; 12: 609-615
  • 18 Cohen SA, Klevens AI. Use of capsule endoscopy in diagnosis and management of pediatric patients, based on meta-analysis. Clin Gastroenterol Hepatol 2011; 9: 490-496
  • 19 Mehdizadeh S, Chen GC, Barkodar L et al. Capsule endoscopy in patients with Crohn’s disease: diagnostic yield and safety. Gastrointest Endosc 2010; 71: 121-127
  • 20 Eliakim R. Video capsule endoscopy of the small bowel. Curr Opin Gastroenterol 2013; 29: 133-139
  • 21 Panes J, Bouhnik Y, Reinisch W et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013; 7: 556-585
  • 22 Spada C, Spera G, Riccioni M et al. A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule. Endoscopy 2005; 37: 793-800
  • 23 Rondonotti E, Herrerias JM, Pennazio M et al. Complications, limitations, and failures of capsule endoscopy: a review of 733 cases. Gastrointest Endosc 2005; 62: 712-716
  • 24 Yadav A, Heigh RI, Hara AK et al. Performance of the patency capsule compared with nonenteroclysis radiologic examinations in patients with known or suspected intestinal strictures. Gastrointest Endosc 2011; 74: 834-839
  • 25 Rozendorn N, Klang E, Lahat A et al. Prediction of patency capsule retention in known Crohn’s disease patients using magnetic resonance imaging. Gastrointest Endosc In press 2015; DOI: http://dx.doi.org/10.1016/j.gie.2015.05.048.
  • 26 Kopylov U, Nemeth A, Koulaouzidis A et al. Small bowel capsule endoscopy in the management of established Crohn’s disease: clinical impact, safety, and correlation with inflammatory biomarkers. Inflamm Bowel Dis 2015; 21: 93-100
  • 27 Niv E, Fishman S, Kachman H et al. Sequential capsule endoscopy of the small bowel for follow-up of patients with known Crohn’s disease. J Crohns Colitis 2014; 8: 1616-1623
  • 28 Flamant M, Trang C, Maillard O et al. The prevalence and outcome of jejunal lesions visualized by small bowel capsule endoscopy in Crohn’s disease. Inflamm Bowel Dis 2013; 19: 1390-1396
  • 29 Esaki M, Matsumoto T, Watanabe K et al. Use of capsule endoscopy in patients with Crohn’s disease in Japan: a multicenter survey. J Gastroenterol Hepatol 2014; 29: 96-101
  • 30 Caunedo-Alvarez A, Romero-Vazquez J, Herrerias-Gutierrez JM. Patency and Agile capsules. World J Gastroenterol 2008; 14: 5269-5273
  • 31 Doherty GA, Moss AC, Cheifetz AS. Capsule endoscopy for small-bowel evaluation in Crohn’s disease. Gastrointest Endosc 2011; 74: 167-175
  • 32 Toth E, Olsson R, Thorlacius H. Clinical evaluation of Given patency system prior to video capsule endoscopy. Endoscopy 2006; 38 (Suppl. 02) A244
  • 33 Assadsangabi A, Blakeborough A, Drew K et al. Small bowel patency assessment using the patency device and a novel targeted (limited radiation) computed tomography based protocol. J Gastroenterol Hepatol 2015; 30: 984-989